Bill
Bill > S00105
NY S00105
NY S00105Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.
summary
Introduced
01/06/2021
01/06/2021
In Committee
01/05/2022
01/05/2022
Crossed Over
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
2021-2022 General Assembly
Bill Summary
AN ACT to amend the insurance law, in relation to requiring health insurance policies to fully cover comprehensive genetic testing and FDA approved biomarker testing for ovarian and prostate cancers
AI Summary
This bill requires health insurance policies to fully cover comprehensive genetic testing and FDA-approved biomarker testing for ovarian and prostate cancers. The coverage is mandatory, regardless of the patient's initial diagnosis, and is also extended to family members of cancer patients. The genetic results cannot be used against family members for insurance coverage purposes. All costs associated with this additional coverage must be borne solely by the insurer and are not subject to annual deductibles or coinsurance.
Committee Categories
Business and Industry
Sponsors (6)
Roxanne Persaud (D)*,
Alessandra Biaggi (D),
Andrew Gounardes (D),
Brad Hoylman (D),
Liz Krueger (D),
Julia Salazar (D),
Last Action
REFERRED TO INSURANCE (on 01/05/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...